A. Gaymon

CRISPR-engineered T cells in patients with refractory cancer

Howard Y. Chang, Wei-Ting Hwang, Frederic D Bushman, 2020, Science.

Long-Term Outcomes From a Randomized Dose Optimization Study of Chimeric Antigen Receptor Modified T Cells in Relapsed Chronic Lymphocytic Leukemia.

D. Porter, B. Levine, C. June, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase I trial of cyclosporine for hospitalized patients with COVID-19

C. June, I. Frank, W. Hwang, 2022, JCI insight.

Anti-CD19 CAR T cells in combination with ibrutinib for the treatment of chronic lymphocytic leukemia

J. Byrd, D. Porter, B. Levine, 2022, Blood advances.